McDonald Ciara, Leask Julie, Chad Nina, Danchin Margie, Fethney Judith, Trevena Lyndal
Faculty of Medicine and Health, School of Medicine, University of Sydney, Sydney 2006, Australia.
ASK NHMRC Centre for Research Excellence, University of Sydney, Sydney 2006, Australia.
Vaccines (Basel). 2020 Sep 2;8(3):500. doi: 10.3390/vaccines8030500.
It is unclear whether information given about the benefits and risks of routine childhood vaccination during consent may cue parental vaccine hesitancy. Parents were surveyed before and after reading vaccine consent information at a public expo event in Sydney, Australia. We measured vaccine hesitancy with Parent Attitudes about Childhood Vaccine Short Scale (PACV-SS), informed decision-making with Informed Subscale of the Decisional Conflict Scale (DCS-IS), items from Stage of Decision Making, Positive Attitude Assessment, Vaccine Safety and Side Effect Concern, and Vaccine Communication Framework (VCF) tools. Overall, 416 parents showed no change in vaccine hesitancy (mean PACV-SS score pre = 1.97, post = 1.94; diff = -0.02 95% CI -0.10 to 0.15) but were more informed (mean DCS-IS score pre = 29.05, post = 7.41; diff = -21.63 95% CI -24.17 to -18.56), were more positive towards vaccination (pre = 43.8% post = 50.4%; diff = 6.5% 95% CI 3.0% to 10.0%), less concerned about vaccine safety (pre = 28.5%, post = 23.0%, diff = -5.6% 95% CI -2.3% to -8.8%) and side effects (pre = 37.0%, post = 29.0%, diff = -8.0% 95% CI -4.0% to -12.0%) with no change in stage of decision-making or intention to vaccinate. Providing information about the benefits and risks of routine childhood vaccination increases parents' informed decision-making without increasing vaccine hesitancy.
目前尚不清楚在获得同意过程中提供的关于儿童常规疫苗接种的益处和风险的信息是否会引发家长对疫苗的犹豫。在澳大利亚悉尼的一次公共展览活动中，对家长在阅读疫苗同意书信息前后进行了调查。我们使用儿童疫苗家长态度简表（PACV - SS）来衡量疫苗犹豫程度，使用决策冲突量表知情子量表（DCS - IS）、决策阶段项目、积极态度评估、疫苗安全性和副作用担忧以及疫苗沟通框架（VCF）工具来衡量知情决策情况。总体而言，416名家长的疫苗犹豫程度没有变化（PACV - SS评分均值：接种前 = 1.97，接种后 = 1.94；差值 = -0.02，95%置信区间 -0.10至0.15），但他们了解得更多了（DCS - IS评分均值：接种前 = 29.05，接种后 = 7.41；差值 = -21.63，95%置信区间 -24.17至 -18.56），对疫苗接种更积极（接种前 = 43.8%，接种后 = 50.4%；差值 = 6.5%，95%置信区间3.0%至 = 10.0%），对疫苗安全性（接种前 = 28.5%，接种后 = 23.0%，差值 = -5.6%，95%置信区间 -2.3%至 -8.8%）和副作用（接种前 = 37.0%，接种后 = 29.0%，差值 = -8.0%，95%置信区间 -当决策阶段或接种意愿没有变化时，提供关于儿童常规疫苗接种的益处和风险的信息可提高家长的知情决策能力，而不会增加疫苗犹豫程度。 4.0%至 -12.0%）。
